Download - PDA Annual2016 - MWJornitz
![Page 1: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/1.jpg)
Necessities and Possibilities of New Manufacturing and Facility Designs
PDA Europe 1st Annual MeetingBerlin, 28-29 June 2016
Maik W. JornitzG-CON Manufacturing Inc.
![Page 2: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/2.jpg)
2
Ø Current Situation & Future Indicators
Ø The Past & The Current
Ø Different Scenarios with Different Needs
Ø Rethinking the Possibilities
Ø Summary
Agenda
![Page 3: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/3.jpg)
3
v Patent cliff for small molecules is reality and affects large molecule industry with coming biosimilars
v Regulatory view is changing and supporting agile, efficient and flexible manufacturing platforms
v Global expansion push to secure APIs and capture local markets
v Process volumes become lower and manufacturing requires to become more flexible for better facility and capacity utilization
v Single-use equipment lacks still the flexibility, when used in traditional facility lay-out
Current Situation
![Page 4: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/4.jpg)
4
v Aging population on the rise with further needs for capacities to avoid stock-outs/drug shortage
v Rising middle class in different countries require in-country/for country manufacturing capacities
v Changing viral and microbial diseases require fast response possibilities utilizing new technologies and deployment methods
v Regenerative/personalized medicines require specific processing systems in accordance with any possible logistic hurdle and robust containment needs
v Continuous processing minimizes processes further
Future Indicators
![Page 5: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/5.jpg)
5
Past Facilities may not fit New Needs
• High CAPEX (>$500M)• Long time-to-run (3-4y)• Product dedicated• Inflexible/non-scalable• Extensive qualification
needs• Difficult containment• Difficult to clone
Changeis
Needed
![Page 6: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/6.jpg)
6
Some New Concept may be Lacking
“Until now, modular facilities have reproduced traditional architecture with regard to embedding utilities piping and HVAC ducts in the interspace between the physical module limits and the suspended ceiling making refurbishment, if required, extremely complicated.
The new approach is to segregate pre-assembled modules into laboratory and utility modules, which are designed such that they permit even simpler and faster construction, qualification, validation and maintenance, respectively….” Alan Pralong (2013)
FLEXIBILITY is KEY
Brick & Mortar Modular Predesigned
![Page 7: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/7.jpg)
7
The Future requires…
ü Speed• Abbreviated design phases
• Time-to-built/Time-to-run
• Adoption of new technologies
ü Agility • Scaling up- and down w/o interruption of existing processes
• Rapidly deployed in multiple locations (in-country/for country)
ü Efficiency• Higher yield per footprint
• Faster turn-around/set-up time
• Multi-product runs (parallel)
• Infrastructures for multi-purpose use
![Page 8: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/8.jpg)
8
Scenario: Precision Medicine
The question of centralized or decentralized (hospital, cancer center, local based, logistics hub, airport location) is still debated (needle to needle logistics for example)
Centralized(hub)
Decentralized(hospitalorcancercenter)
Takeapart
Re-assemble
![Page 9: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/9.jpg)
9
Single-use technology processes create flexibility & speed, but…
…is only as flexible as the surrounding infrastructure !
Courtesy Stedim
Scenario: SUT Implementation
Courtesy G-CON Manufacturing
Courtesy GE
![Page 10: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/10.jpg)
10
Change
TraditionalHardwall Modular (Containerbased) Assembled
Change
e.g. 10,000L bioreactor transition to multiple 2,000L systems
Scenario: Compression & Diversification
Courtesy Pharmadule
![Page 11: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/11.jpg)
11
Scenario: Multi-product/-tenant
Courtesy FujiFilm Diosynth
![Page 12: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/12.jpg)
12
Courtesy: GE
Built off-site à Assembled on-site to a facility, example JHL China
Example: MAb Processing
![Page 13: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/13.jpg)
13
Example: MAb ProcessingBuilt off-site à Assembled on-site to a repurposable, multi-product cleanroom infrastructure, example Just Biotherapeutics, China
Courtesy: Just Biotherapeutics, AES, G-CON Manufacturing Inc.
![Page 14: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/14.jpg)
14
Prefabricated OSD Site
Courtesy: Pfizer, Groton, CT, USA
Prefabricated Aseptic Filling Site
Courtesy: University of Tennessee, Memphis, TN, USA
Example: OSD & Aseptic Filling
![Page 15: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/15.jpg)
15
Rethinking – Facility Catalogue ?!
We select Process Equipment from a Catalogue, can we do the same for Facilities in future ?
(at least cleanroom infrastructures)
Creating UnitOperations
Courtesy M+W
StandardizingPlatforms
Courtesy G-CON Manufacturing Inc.
PredesigningStructures
Courtesy NNE Pharmaplan
![Page 16: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/16.jpg)
16
Rethinking – Facility Catalogue ?!
We select Process Equipment from a Catalogue, can we do the same for Facilities in future ?
Abbreviation ofDesign Phases
Known Qualification Tasks
Set Timelines & Scopes
Regulatory Familiarity
Cloning of Training & Procedures
InitialMeeting
Conceptual Layout
Conceptual DesignDetailed Design
Basic/Schematic Design
StartupCommissioning
AcceptanceofDrawings
1-2Weeks 4-8Weeks 10-12Weeks1- 2Days
Platform catalogue/redlining
![Page 17: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/17.jpg)
17
Summary
Ø Current, prevalent facility/process designs become outdated and strain to meet pressing industry requirements and application needs
Ø Facilities require to adopt mobility in case of processing and location decision delays or being repurposable, instead of “mothballed”
Ø ”Platinum standard” aseptic processing requires to be accommodated within robust and strict containment options
Ø Multi-product/multi-purpose facilities become a prevalent request to gain capacity utilization
Ø Facility deployment requires much faster (< 1 year built) and possibly clonable
![Page 18: PDA Annual2016 - MWJornitz](https://reader034.vdocument.in/reader034/viewer/2022052606/58f212481a28ab17628b459b/html5/thumbnails/18.jpg)
Thank you [email protected]
“The arrogance of success is to think that what you did yesterday will be sufficient for tomorrow”
William Pollard